Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 15.58
+0.19 (1.23%)
Sep 4, 2026, 3:00 PM CST
Guobang Pharma Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 6,105 | 5,988 | 5,867 | 5,327 | 5,704 | 4,493 |
Other Revenue | 22.12 | 23.8 | 23.85 | 22.35 | 17.33 | 12.43 |
| 6,128 | 6,011 | 5,891 | 5,349 | 5,721 | 4,505 | |
Revenue Growth | 1.71% | 2.05% | 10.12% | -6.49% | 26.98% | 7.11% |
Cost of Revenue | 4,665 | 4,483 | 4,455 | 4,141 | 4,190 | 3,212 |
Gross Profit | 1,462 | 1,528 | 1,435 | 1,209 | 1,531 | 1,294 |
Selling, General & Admin | 387.54 | 366.34 | 345.57 | 365.25 | 339.93 | 297.29 |
Research & Development | 210.72 | 209.83 | 215.05 | 190.51 | 197.54 | 155.27 |
Other Operating Expenses | 45.12 | 32.27 | 26.73 | 30.96 | 31.9 | 23.67 |
Operating Expenses | 645.58 | 614.1 | 599.43 | 579.55 | 581.08 | 478.27 |
Operating Income | 816.86 | 914.38 | 835.91 | 629.3 | 949.97 | 815.55 |
Interest Expense | -23.24 | -23.92 | -27.28 | -22.58 | -16.55 | -28.72 |
Interest & Investment Income | 31.05 | 34.56 | 42.89 | 65 | 48.9 | 22.66 |
Currency Exchange Gain (Loss) | -48.88 | -9.17 | 32.46 | 22.04 | 58.72 | -14.48 |
Other Non Operating Income (Expenses) | -3.04 | -4.42 | -5.48 | -7.41 | -4.31 | -2.13 |
EBT Excluding Unusual Items | 772.74 | 911.43 | 878.5 | 686.35 | 1,037 | 792.88 |
Gain (Loss) on Sale of Investments | 12.02 | 12.92 | 14.4 | 10.34 | 4.56 | 6.26 |
Gain (Loss) on Sale of Assets | 23.62 | 24.81 | -9.11 | 0.72 | -15.84 | 0.3 |
Asset Writedown | -7.67 | -7.67 | -6.54 | -5.8 | -0.05 | -9.31 |
Other Unusual Items | 17.07 | 9.76 | 10.71 | 6.04 | 10.24 | 16.65 |
Pretax Income | 817.79 | 951.26 | 887.97 | 697.65 | 1,036 | 806.78 |
Income Tax Expense | 112.89 | 133.69 | 107.39 | 87.67 | 115.02 | 100.55 |
Earnings From Continuing Operations | 704.9 | 817.57 | 780.58 | 609.98 | 920.62 | 706.23 |
Minority Interest in Earnings | 1.7 | 3.25 | 1.02 | 2.49 | 0.28 | -0.2 |
Net Income | 706.6 | 820.82 | 781.6 | 612.46 | 920.9 | 706.03 |
Net Income to Common | 706.6 | 820.82 | 781.6 | 612.46 | 920.9 | 706.03 |
Net Income Growth | -15.13% | 5.02% | 27.62% | -33.49% | 30.43% | -12.84% |
Shares Outstanding (Basic) | 772 | 776 | 782 | 780 | 781 | 716 |
Shares Outstanding (Diluted) | 772 | 776 | 782 | 780 | 781 | 716 |
Shares Change | -1.87% | -0.65% | 0.27% | -0.24% | 9.09% | 8.01% |
EPS (Basic) | 0.92 | 1.06 | 1.00 | 0.79 | 1.18 | 0.99 |
EPS (Diluted) | 0.92 | 1.06 | 1.00 | 0.79 | 1.18 | 0.99 |
EPS Growth | -13.51% | 5.71% | 27.27% | -33.34% | 19.57% | -19.30% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 462.51 | 281.57 | 287.29 | -231.68 | 213.92 | -624.23 |
Free Cash Flow Per Share | 0.60 | 0.36 | 0.37 | -0.30 | 0.27 | -0.87 |
Dividend Per Share | 0.429 | 0.429 | 0.433 | 0.215 | 0.429 | 0.500 |
Dividend Growth | -0.95% | -0.95% | 100.88% | -49.74% | -14.28% | - |
Gross Margin | 23.87% | 25.43% | 24.37% | 22.60% | 26.76% | 28.72% |
Operating Margin | 13.33% | 15.21% | 14.19% | 11.76% | 16.61% | 18.10% |
Profit Margin | 11.53% | 13.65% | 13.27% | 11.45% | 16.10% | 15.67% |
Free Cash Flow Margin | 7.55% | 4.68% | 4.88% | -4.33% | 3.74% | -13.86% |
EBITDA | 1,304 | 1,391 | 1,269 | 950.43 | 1,210 | 1,016 |
EBITDA Margin | 21.29% | 23.14% | 21.55% | 17.77% | 21.15% | 22.56% |
D&A For EBITDA | 487.37 | 476.96 | 433.38 | 321.14 | 260.21 | 200.9 |
EBIT | 816.86 | 914.38 | 835.91 | 629.3 | 949.97 | 815.55 |
EBIT Margin | 13.33% | 15.21% | 14.19% | 11.76% | 16.61% | 18.10% |
Effective Tax Rate | 13.80% | 14.05% | 12.09% | 12.57% | 11.11% | 12.46% |
Revenue as Reported | 6,128 | 6,011 | 5,891 | 5,349 | 5,721 | 4,505 |
Advertising Expenses | - | 2.66 | 1.94 | 1.52 | 3.42 | 1.2 |